ALBUMIN HUMAN

ALBUMIN HUMAN was reported 4967 times

ALBUMIN HUMAN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ACCESSORY MUSCLE 3 0.5000
1 ATRIAL RUPTURE 3 0.1500
2 KIDNEY MALROTATION 6 0.1463
3 PERIUMBILICAL ABSCESS 8 0.1194
4 CARDIAC PSEUDOANEURYSM 4 0.0580
5 TRANSFUSION-RELATED CIRCULATORY OVERLOAD 14 0.0579
6 CATHETER SITE ABSCESS 8 0.0460
7 TRANSFUSION-RELATED ACUTE LUNG INJURY 14 0.0455
8 MONOCYTOSIS 28 0.0451
9 PHOSPHOLIPIDOSIS 4 0.0404
10 ALLERGIC TRANSFUSION REACTION 6 0.0397
11 CARDIAC CIRRHOSIS 4 0.0388
12 PLEURAL CALCIFICATION 4 0.0348
13 FEBRILE NONHAEMOLYTIC TRANSFUSION REACTION 6 0.0319
14 PORTAL TRACT INFLAMMATION 4 0.0317
15 ADMINISTRATION SITE INFECTION 3 0.0316
16 DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY 29 0.0306
17 CELL-MEDIATED IMMUNE DEFICIENCY 4 0.0286
18 CERVIX CARCINOMA RECURRENT 5 0.0281
19 POSTOPERATIVE RENAL FAILURE 4 0.0276
20 MECHANICAL VENTILATION COMPLICATION 4 0.0268
21 SYMBLEPHARON 7 0.0268
22 HEPATIC VEIN OCCLUSION 4 0.0253
23 BURKHOLDERIA TEST POSITIVE 3 0.0242
24 TRI-IODOTHYRONINE FREE DECREASED 6 0.0235
25 MULTISYSTEM INFLAMMATORY SYNDROME 4 0.0231
26 VAGINAL LESION 7 0.0229
27 URINARY TRACT INFLAMMATION 8 0.0222
28 CONDUCTIVE DEAFNESS 7 0.0218
29 MORGANELLA INFECTION 6 0.0205
30 PORTAL FIBROSIS 4 0.0187
31 CANDIDA PNEUMONIA 6 0.0186
32 HISTAMINE LEVEL INCREASED 4 0.0184
33 HYPOPROTEINAEMIA 34 0.0179
34 CAPILLARY LEAK SYNDROME 36 0.0174
35 EXPOSURE TO SARS-COV-2 27 0.0159
36 NECROTISING COLITIS 20 0.0158
37 BONE MARROW INFILTRATION 6 0.0155
38 RED BLOOD CELL SCHISTOCYTES PRESENT 5 0.0154
39 MORAXELLA INFECTION 4 0.0146
40 INSPIRATORY CAPACITY DECREASED 4 0.0144
41 HAEMORRHAGIC ASCITES 4 0.0140
42 EPIDERMOLYSIS 6 0.0130
43 GASTROENTERITIS ROTAVIRUS 4 0.0130
44 INCREASED DOSE ADMINISTERED 4 0.0128
45 HAEMOPERITONEUM 10 0.0125
46 HYPOALBUMINAEMIA 96 0.0123
47 NEUROPSYCHOLOGICAL SYMPTOMS 7 0.0116
48 PRODUCT INEFFECTIVE 9 0.0115
49 DELAYED GRAFT FUNCTION 8 0.0113
50 CARDIOVASCULAR INSUFFICIENCY 18 0.0110
51 HUMORAL IMMUNE DEFECT 4 0.0108
52 LUNG INFECTION PSEUDOMONAL 6 0.0108
53 PANCREATIC PSEUDOCYST 8 0.0103
54 MULTI-ORGAN FAILURE 173 0.0100
55 ULCERATIVE KERATITIS 27 0.0098
56 ASPERGILLUS TEST POSITIVE 3 0.0097
57 BLOOD FIBRINOGEN DECREASED 11 0.0096
58 OSMOTIC DEMYELINATION SYNDROME 7 0.0095
59 ACINETOBACTER INFECTION 10 0.0091
60 ABDOMINAL SEPSIS 8 0.0091
61 PORTAL HYPERTENSIVE GASTROPATHY 5 0.0089
62 TUMOUR FLARE 6 0.0088
63 URINARY TRACT INFECTION FUNGAL 5 0.0087
64 ENTEROCOCCAL SEPSIS 7 0.0086
65 SKIN TEST POSITIVE 8 0.0086
66 PANCREATITIS RELAPSING 7 0.0086
67 KLEBSIELLA INFECTION 43 0.0085
68 ENGRAFTMENT SYNDROME 5 0.0085
69 ADENOMA BENIGN 7 0.0081
70 FEAR 219 0.0081
71 HEPATORENAL SYNDROME 13 0.0077
72 ENCEPHALITIS AUTOIMMUNE 10 0.0076
73 RETROPERITONEAL LYMPHADENOPATHY 4 0.0076
74 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 29 0.0076
75 LUNG TRANSPLANT REJECTION 5 0.0076
76 TOXIC EPIDERMAL NECROLYSIS 111 0.0073
77 LIVEDO RETICULARIS 15 0.0072
78 PROTEUS INFECTION 5 0.0070
79 HILAR LYMPHADENOPATHY 6 0.0068
80 CRYSTAL NEPHROPATHY 4 0.0068
81 RESPIRATORY TRACT HAEMORRHAGE 4 0.0067
82 CAECITIS 3 0.0067
83 RENAL INJURY 197 0.0066
84 BILIARY TRACT INFECTION 4 0.0064
85 KIDNEY ENLARGEMENT 7 0.0064
86 SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT 8 0.0064
87 ENDOCARDITIS BACTERIAL 5 0.0064
88 PRODUCT CONFUSION 5 0.0063
89 HYPERCHLORAEMIA 4 0.0063
90 SPUTUM CULTURE POSITIVE 5 0.0062
91 ASPERGILLOSIS 8 0.0061
92 SEPTIC EMBOLUS 5 0.0060
93 ANHEDONIA 156 0.0059
94 SURGICAL PROCEDURE REPEATED 4 0.0058
95 FEAR OF DEATH 13 0.0058
96 PSEUDOMONAL SEPSIS 10 0.0057
97 STAPHYLOCOCCUS TEST POSITIVE 12 0.0057
98 TRYPTASE INCREASED 4 0.0056
99 LIP EROSION 4 0.0055
100 PUPILLARY REFLEX IMPAIRED 10 0.0054
101 COMA HEPATIC 4 0.0054
102 TACHYPNOEA 72 0.0053
103 MALIGNANT ASCITES 4 0.0052
104 HEPATIC NEOPLASM MALIGNANT 11 0.0052
105 COAGULATION TIME PROLONGED 8 0.0052
106 STENOTROPHOMONAS INFECTION 7 0.0052
107 CONTINUOUS HAEMODIAFILTRATION 5 0.0051
108 SUBCUTANEOUS EMPHYSEMA 5 0.0051
109 HEPARIN-INDUCED THROMBOCYTOPENIA 25 0.0051
110 HYPOFIBRINOGENAEMIA 5 0.0050
111 DIABETES INSIPIDUS 12 0.0050
112 DISSEMINATED INTRAVASCULAR COAGULATION 70 0.0050
113 PNEUMONIA KLEBSIELLA 9 0.0049
114 HYDROTHORAX 4 0.0048
115 ADRENAL SUPPRESSION 4 0.0047
116 ASCITES 139 0.0047
117 HYPERPYREXIA 20 0.0047
118 PANCREATIC CYST 9 0.0047
119 PROCEDURAL HYPOTENSION 4 0.0047
120 SLOW RESPONSE TO STIMULI 6 0.0046
121 HYPERNATRAEMIA 23 0.0046
122 GENERALISED OEDEMA 57 0.0046
123 TRANSFUSION REACTION 4 0.0046
124 PNEUMONIA FUNGAL 18 0.0046
125 PSEUDOMEMBRANOUS COLITIS 10 0.0045
126 ACUTE LEFT VENTRICULAR FAILURE 3 0.0045
127 TACHYARRHYTHMIA 11 0.0044
128 BILIRUBIN CONJUGATED INCREASED 10 0.0043
129 BRASH SYNDROME 6 0.0043
130 FEBRILE INFECTION 5 0.0042
131 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 6 0.0042
132 DELAYED RECOVERY FROM ANAESTHESIA 4 0.0042
133 HAEMODYNAMIC INSTABILITY 32 0.0042
134 OLIGURIA 26 0.0042
135 PNEUMOCYSTIS JIROVECII INFECTION 5 0.0042
136 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 21 0.0041
137 HYPERURICAEMIA 17 0.0041
138 B-CELL TYPE ACUTE LEUKAEMIA 3 0.0041
139 DUODENAL PERFORATION 4 0.0041
140 MATERNAL EXPOSURE DURING DELIVERY 4 0.0040
141 KIDNEY TRANSPLANT REJECTION 19 0.0040
142 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 13 0.0039
143 ORAL MUCOSAL ERUPTION 6 0.0039
144 LIVER TRANSPLANT REJECTION 7 0.0039
145 STEVENS-JOHNSON SYNDROME 86 0.0039
146 CHEST INJURY 8 0.0039
147 OVARIAN HYPERSTIMULATION SYNDROME 9 0.0039
148 INJURY 270 0.0038
149 OSTEOSCLEROSIS 6 0.0038
150 BLOOD FIBRINOGEN INCREASED 3 0.0038
151 HYPOPERFUSION 4 0.0038
152 HAEMOTHORAX 11 0.0038
153 CYTOKINE RELEASE SYNDROME 76 0.0038
154 INTRA-ABDOMINAL HAEMORRHAGE 9 0.0038
155 PSEUDOMONAS INFECTION 32 0.0037
156 BRONCHOPULMONARY DYSPLASIA 3 0.0037
157 TYPE I HYPERSENSITIVITY 13 0.0037
158 BACTERIAL SEPSIS 12 0.0037
159 BLOOD ALBUMIN DECREASED 29 0.0037
160 ISCHAEMIC HEPATITIS 5 0.0036
161 HYPERCAPNIA 11 0.0036
162 VENOOCCLUSIVE LIVER DISEASE 18 0.0036
163 MULTIPLE ORGAN DYSFUNCTION SYNDROME 102 0.0036
164 GASTRIC DILATATION 6 0.0036
165 PNEUMONIA STAPHYLOCOCCAL 7 0.0035
166 PNEUMATOSIS INTESTINALIS 10 0.0035
167 NEPHROTIC SYNDROME 24 0.0035
168 ACUTE RESPIRATORY FAILURE 67 0.0035
169 SEPTIC SHOCK 151 0.0035
170 ESCHERICHIA SEPSIS 10 0.0034
171 ADENOVIRUS INFECTION 10 0.0034
172 SYSTEMIC MYCOSIS 4 0.0034
173 NODAL RHYTHM 5 0.0034
174 HYPOCHLORAEMIA 4 0.0034
175 INCISION SITE PAIN 4 0.0034
176 PANCREATITIS CHRONIC 8 0.0034
177 GASTROINTESTINAL WALL THICKENING 5 0.0033
178 BLOOD CULTURE POSITIVE 10 0.0033
179 ANAEMIA OF CHRONIC DISEASE 3 0.0033
180 LARGE INTESTINAL ULCER 9 0.0033
181 IMMUNE-MEDIATED LUNG DISEASE 6 0.0033
182 UNEVALUABLE EVENT 248 0.0033
183 HYPERPHOSPHATAEMIA 7 0.0033
184 HYPOVOLAEMIA 19 0.0032
185 SYSTEMIC CANDIDA 8 0.0032
186 HYPOXIA 112 0.0032
187 NEONATAL DISORDER 5 0.0032
188 MECHANICAL VENTILATION 6 0.0032
189 MALLORY-WEISS SYNDROME 4 0.0031
190 CYTOMEGALOVIRUS VIRAEMIA 14 0.0031
191 LYMPHADENOPATHY MEDIASTINAL 6 0.0031
192 ENTEROCOCCAL INFECTION 15 0.0031
193 SHOCK HAEMORRHAGIC 25 0.0031
194 RENAL FAILURE ACUTE 130 0.0031
195 OCCULT BLOOD POSITIVE 6 0.0031
196 HYPOKALAEMIA 141 0.0031
197 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 18 0.0030
198 STAPHYLOCOCCAL SEPSIS 15 0.0030
199 RENAL IMPAIRMENT 254 0.0030
200 HYPERTRANSAMINASAEMIA 21 0.0030
201 RESUSCITATION 5 0.0030
202 RENAL FAILURE 394 0.0030
203 CLOSTRIDIAL INFECTION 10 0.0030
204 BLOOD UREA INCREASED 49 0.0029
205 SHOCK 67 0.0029
206 FUNCTIONAL GASTROINTESTINAL DISORDER 10 0.0029
207 PERITONEAL HAEMORRHAGE 4 0.0029
208 DIABETIC METABOLIC DECOMPENSATION 4 0.0029
209 SUSPECTED OFF LABEL USE 13 0.0029
210 CULTURE URINE POSITIVE 4 0.0028
211 JAUNDICE CHOLESTATIC 10 0.0028
212 EYE INFLAMMATION 27 0.0028
213 BLOOD IMMUNOGLOBULIN G DECREASED 7 0.0028
214 BLOOD BILIRUBIN INCREASED 76 0.0028
215 HYPOCALCAEMIA 53 0.0028
216 FLUID INTAKE REDUCED 14 0.0028
217 COVID-19 PNEUMONIA 33 0.0028
218 GRAFT VERSUS HOST DISEASE 20 0.0028
219 BRAIN OEDEMA 35 0.0028
220 STAPHYLOCOCCAL BACTERAEMIA 12 0.0028
221 ABDOMINAL INFECTION 7 0.0027
222 CLOSTRIDIUM DIFFICILE COLITIS 29 0.0027
223 ORGAN FAILURE 11 0.0027
224 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 6 0.0027
225 OPPORTUNISTIC INFECTION 5 0.0027
226 BACTERAEMIA 32 0.0027
227 HEPATIC ENCEPHALOPATHY 25 0.0027
228 ACUTE PULMONARY OEDEMA 15 0.0027
229 EMBOLISM 22 0.0026
230 CYTOMEGALOVIRUS INFECTION 44 0.0026
231 VARICES OESOPHAGEAL 8 0.0026
232 ANAPHYLACTIC SHOCK 68 0.0026
233 RESPIRATORY FAILURE 192 0.0026
234 LYMPHOCYTE COUNT DECREASED 46 0.0026
235 ACUTE PRERENAL FAILURE 3 0.0026
236 PULMONARY OEDEMA 116 0.0026
237 HAEMOLYTIC URAEMIC SYNDROME 6 0.0026
238 NEPHROPATHY TOXIC 29 0.0026
239 CARDIOPULMONARY FAILURE 10 0.0026
240 ACUTE LUNG INJURY 3 0.0025
241 HEPATITIS E 4 0.0025
242 CACHEXIA 13 0.0025
243 COAGULOPATHY 42 0.0025
244 LUNG CONSOLIDATION 7 0.0025
245 TUMOUR LYSIS SYNDROME 22 0.0025
246 ENCEPHALOPATHY 61 0.0025
247 PLEURAL EFFUSION 151 0.0025
248 BLOOD IMMUNOGLOBULIN G INCREASED 3 0.0025
249 OSTEOLYSIS 5 0.0024
250 AMYLASE INCREASED 9 0.0024
251 QUADRIPLEGIA 5 0.0024
252 SUFFOCATION FEELING 6 0.0024
253 SKIN INDURATION 5 0.0024
254 VENA CAVA THROMBOSIS 4 0.0024
255 STEM CELL TRANSPLANT 6 0.0024
256 OLIGOHYDRAMNIOS 8 0.0024
257 INTESTINAL ISCHAEMIA 13 0.0024
258 CYANOSIS 37 0.0024
259 BLOOD CREATINE PHOSPHOKINASE MB INCREASED 3 0.0023
260 SARS-COV-2 TEST POSITIVE 31 0.0023
261 PROTHROMBIN TIME PROLONGED 14 0.0023
262 BLOOD PH DECREASED 4 0.0023
263 HEPATOSPLENOMEGALY 6 0.0023
264 BLOOD AMYLASE INCREASED 4 0.0023
265 LYMPHOCYTOSIS 5 0.0023
266 BRONCHOPULMONARY ASPERGILLOSIS 18 0.0023
267 BILIARY OBSTRUCTION 3 0.0023
268 SKIN NECROSIS 12 0.0023
269 EXTREMITY NECROSIS 4 0.0023
270 RENAL TUBULAR ACIDOSIS 5 0.0023
271 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 6 0.0023
272 HEPATIC FAILURE 69 0.0023
273 URINE OUTPUT DECREASED 20 0.0023
274 DUODENITIS 7 0.0023
275 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 5 0.0023
276 NEUROLOGICAL SYMPTOM 13 0.0023
277 PARAPARESIS 4 0.0022
278 PNEUMOCYSTIS JIROVECI PNEUMONIA 5 0.0022
279 CYTOMEGALOVIRUS TEST POSITIVE 4 0.0022
280 RENAL TUBULAR NECROSIS 22 0.0022
281 TRANSPLANT DYSFUNCTION 4 0.0022
282 EPSTEIN-BARR VIRUS INFECTION 14 0.0022
283 URINE ABNORMALITY 10 0.0022
284 PORTAL VEIN THROMBOSIS 7 0.0022
285 WOUND HAEMORRHAGE 8 0.0022
286 ACUTE RESPIRATORY DISTRESS SYNDROME 38 0.0021
287 MALNUTRITION 24 0.0021
288 FOETAL GROWTH RESTRICTION 13 0.0021
289 PROTEIN TOTAL DECREASED 8 0.0021
290 HYPERBILIRUBINAEMIA 22 0.0021
291 INTERVERTEBRAL DISCITIS 4 0.0021
292 DUODENAL ULCER HAEMORRHAGE 6 0.0021
293 RENAL FAILURE CHRONIC 16 0.0021
294 SEPSIS 232 0.0021
295 ATELECTASIS 20 0.0021
296 TRANSPLANT FAILURE 5 0.0020
297 HYPERVOLAEMIA 10 0.0020
298 AUTOIMMUNE HEPATITIS 14 0.0020
299 HYPERAMMONAEMIA 10 0.0020
300 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 15 0.0020
301 VENOOCCLUSIVE DISEASE 5 0.0020
302 HEPATITIS CHOLESTATIC 12 0.0020
303 GANGRENE 12 0.0020
304 NEPHROGENIC SYSTEMIC FIBROSIS 6 0.0020
305 ASPERGILLUS INFECTION 13 0.0020
306 TOXIC ENCEPHALOPATHY 10 0.0020
307 FIBRIN D DIMER INCREASED 7 0.0020
308 CONJUNCTIVAL HYPERAEMIA 7 0.0020
309 CARDIAC FAILURE ACUTE 13 0.0019
310 CARDIOGENIC SHOCK 28 0.0019
311 THROMBOTIC MICROANGIOPATHY 19 0.0019
312 CONGESTIVE CARDIOMYOPATHY 8 0.0019
313 COMPARTMENT SYNDROME 5 0.0019
314 DERMATITIS ALLERGIC 24 0.0019
315 RALES 11 0.0019
316 LOWER GASTROINTESTINAL HAEMORRHAGE 14 0.0019
317 PULSE ABSENT 9 0.0019
318 ESCHERICHIA URINARY TRACT INFECTION 8 0.0019
319 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 5 0.0019
320 AREFLEXIA 5 0.0019
321 ACUTE LEUKAEMIA 3 0.0019
322 OESOPHAGEAL VARICES HAEMORRHAGE 4 0.0018
323 NEUTROPHIL COUNT DECREASED 75 0.0018
324 ACIDOSIS 14 0.0018
325 HEPATITIS B 11 0.0018
326 CIRCULATORY COLLAPSE 31 0.0018
327 LUNG INFILTRATION 16 0.0018
328 ANTIBODY TEST POSITIVE 3 0.0018
329 BLOOD CREATINE INCREASED 8 0.0018
330 MACULE 5 0.0018
331 RESPIRATORY RATE INCREASED 16 0.0018
332 BACTERIAL TEST POSITIVE 4 0.0018
333 PULMONARY ALVEOLAR HAEMORRHAGE 10 0.0018
334 WOUND DEHISCENCE 6 0.0018
335 HEPATOCELLULAR DAMAGE 4 0.0018
336 COMPLICATIONS OF TRANSPLANTED KIDNEY 4 0.0018
337 PATHOGEN RESISTANCE 16 0.0018
338 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 45 0.0017
339 TRANSPLANT REJECTION 14 0.0017
340 PANCREATITIS NECROTISING 4 0.0017
341 PERIORBITAL OEDEMA 9 0.0017
342 HEPATOMEGALY 17 0.0017
343 METHAEMOGLOBINAEMIA 4 0.0017
344 HYPOMAGNESAEMIA 24 0.0017
345 PERIPHERAL ISCHAEMIA 7 0.0017
346 OXYGEN SATURATION DECREASED 96 0.0017
347 PULMONARY INFARCTION 4 0.0017
348 FEBRILE NEUTROPENIA 112 0.0017
349 ACUTE HEPATIC FAILURE 23 0.0017
350 AORTIC VALVE STENOSIS 3 0.0017
351 BRONCHOSPASM 24 0.0017
352 SUPRAVENTRICULAR TACHYCARDIA 16 0.0017
353 NORMOCHROMIC NORMOCYTIC ANAEMIA 5 0.0017
354 HEPATIC FUNCTION ABNORMAL 62 0.0017
355 PRODUCT PACKAGING CONFUSION 4 0.0016
356 PSYCHIATRIC SYMPTOM 12 0.0016
357 HYPERKALAEMIA 57 0.0016
358 HYPOPHOSPHATAEMIA 12 0.0016
359 SPLENOMEGALY 19 0.0016
360 PORTAL HYPERTENSION 5 0.0016
361 INFLAMMATORY MARKER INCREASED 8 0.0016
362 CHOLANGITIS 10 0.0016
363 EMOTIONAL DISTRESS 195 0.0016
364 PROTEIN URINE PRESENT 8 0.0016
365 ASPARTATE AMINOTRANSFERASE INCREASED 85 0.0016
366 HEPATIC CIRRHOSIS 30 0.0016
367 VENTRICULAR HYPERTROPHY 4 0.0016
368 RESPIRATORY RATE DECREASED 5 0.0016
369 CYTOMEGALOVIRUS INFECTION REACTIVATION 7 0.0016
370 GAMMA-GLUTAMYLTRANSFERASE INCREASED 35 0.0016
371 ORTHOPNOEA 5 0.0016
372 PAPULE 11 0.0016
373 ENTEROCOLITIS 9 0.0016
374 RESPIRATORY DISTRESS 43 0.0016
375 CUSHINGOID 5 0.0016
376 VENTRICULAR HYPOKINESIA 5 0.0016
377 BACTERIAL INFECTION 29 0.0016
378 AORTIC ARTERIOSCLEROSIS 4 0.0016
379 CONGENITAL ANOMALY 12 0.0015
380 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 4 0.0015
381 ELECTROLYTE IMBALANCE 18 0.0015
382 VASCULAR DEVICE INFECTION 7 0.0015
383 PULMONARY HAEMORRHAGE 12 0.0015
384 TORSADE DE POINTES 12 0.0015
385 HYPOGAMMAGLOBULINAEMIA 10 0.0015
386 SERUM FERRITIN INCREASED 8 0.0015
387 OTITIS MEDIA 5 0.0015
388 LOCALISED OEDEMA 7 0.0015
389 ANURIA 13 0.0015
390 LOW BIRTH WEIGHT BABY 12 0.0015
391 ALLERGIC REACTION TO EXCIPIENT 3 0.0015
392 CEREBRAL ATROPHY 6 0.0015
393 ANXIETY DISORDER 5 0.0015
394 CANDIDIASIS 6 0.0015
395 LEUKOCYTOSIS 27 0.0015
396 BK VIRUS INFECTION 5 0.0015
397 BRADYPNOEA 4 0.0015
398 POLYURIA 12 0.0015
399 NEUTROPHIL COUNT INCREASED 15 0.0015
400 HYPOVOLAEMIC SHOCK 7 0.0015
401 BRONCHOPNEUMONIA 5 0.0015
402 TEMPERATURE INTOLERANCE 15 0.0015
403 LEFT VENTRICULAR FAILURE 5 0.0015
404 BLOOD LACTATE DEHYDROGENASE INCREASED 23 0.0015
405 PNEUMOTHORAX 23 0.0014
406 STILLBIRTH 7 0.0014
407 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 4 0.0014
408 VENTRICULAR FIBRILLATION 16 0.0014
409 HYPOTENSION 288 0.0014
410 LIPASE INCREASED 11 0.0014
411 ANAPHYLACTIC REACTION 79 0.0014
412 ANGIOPATHY 8 0.0014
413 ENDOTRACHEAL INTUBATION 4 0.0014
414 SKIN HYPERTROPHY 4 0.0014
415 THROMBOTIC THROMBOCYTOPENIC PURPURA 5 0.0014
416 ACUTE LYMPHOCYTIC LEUKAEMIA 4 0.0014
417 OXYGEN SATURATION ABNORMAL 4 0.0014
418 POLYP 9 0.0014
419 BLOOD CREATININE INCREASED 89 0.0014
420 IMMUNOSUPPRESSION 12 0.0014
421 HEPATITIS FULMINANT 4 0.0013
422 HISTIOCYTOSIS HAEMATOPHAGIC 4 0.0013
423 ILEUS PARALYTIC 6 0.0013
424 ALANINE AMINOTRANSFERASE INCREASED 82 0.0013
425 PLATELET COUNT DECREASED 142 0.0013
426 BLOOD LACTIC ACID INCREASED 7 0.0013
427 BLOOD ALKALINE PHOSPHATASE INCREASED 33 0.0013
428 HEPATITIS C 16 0.0013
429 BLOOD LOSS ANAEMIA 3 0.0013
430 CARDIAC FAILURE 106 0.0013
431 BLOOD PRESSURE SYSTOLIC DECREASED 6 0.0013
432 NEUROTOXICITY 23 0.0013
433 HAEMODIALYSIS 11 0.0013
434 FIBROSIS 4 0.0013
435 LARYNGEAL OEDEMA 8 0.0013
436 BRAIN NATRIURETIC PEPTIDE INCREASED 4 0.0013
437 LARGE INTESTINE PERFORATION 9 0.0013
438 NEPHROGENIC ANAEMIA 6 0.0013
439 ILEUS 16 0.0013
440 CARDIOMYOPATHY 19 0.0013
441 HYPOTHERMIA 13 0.0013
442 BLOOD BLISTER 4 0.0013
443 HYPONATRAEMIA 72 0.0013
444 STAPHYLOCOCCAL INFECTION 42 0.0013
445 HAEMORRHAGE INTRACRANIAL 19 0.0013
446 ELECTROENCEPHALOGRAM ABNORMAL 4 0.0013
447 SUSPECTED COUNTERFEIT PRODUCT 5 0.0013
448 RESPIRATORY SYNCYTIAL VIRUS INFECTION 11 0.0013
449 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 12 0.0013
450 PNEUMONIA VIRAL 4 0.0013
451 OEDEMA 68 0.0013
452 METABOLIC ACIDOSIS 40 0.0012
453 PURPURA 11 0.0012
454 CYSTITIS HAEMORRHAGIC 5 0.0012
455 FLUID OVERLOAD 18 0.0012
456 PANCYTOPENIA 69 0.0012
457 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 4 0.0012
458 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 5 0.0012
459 BLOOD PRESSURE DECREASED 81 0.0012
460 HAEMATOCRIT DECREASED 24 0.0012
461 CYTOLYTIC HEPATITIS 4 0.0012
462 LYMPHOPENIA 17 0.0012
463 UNRESPONSIVE TO STIMULI 31 0.0012
464 DYSPHORIA 6 0.0012
465 DRUG ERUPTION 21 0.0012
466 SUPRAVENTRICULAR EXTRASYSTOLES 4 0.0012
467 PNEUMONITIS 32 0.0012
468 CARDIAC ARREST 97 0.0012
469 HAEMOLYSIS 9 0.0012
470 PNEUMONIA ASPIRATION 29 0.0012
471 FAILURE TO THRIVE 6 0.0012
472 JAUNDICE 31 0.0012
473 THROMBOCYTOPENIA 128 0.0011
474 MYOCARDIAL ISCHAEMIA 13 0.0011
475 MYELOSUPPRESSION 41 0.0011
476 DEPRESSIVE SYMPTOM 4 0.0011
477 HYPERCALCAEMIA 14 0.0011
478 PERICARDIAL EFFUSION 26 0.0011
479 PRODUCT CONTAMINATION 4 0.0011
480 RENAL TRANSPLANT 4 0.0011
481 DERMATITIS BULLOUS 8 0.0011
482 DECUBITUS ULCER 9 0.0011
483 TACHYCARDIA 98 0.0011
484 SCLERODERMA 4 0.0011
485 LEUKOPENIA 55 0.0011
486 C-REACTIVE PROTEIN INCREASED 40 0.0011
487 WHITE BLOOD CELL COUNT INCREASED 42 0.0011
488 BLOOD PHOSPHORUS DECREASED 4 0.0011
489 ACUTE GRAFT VERSUS HOST DISEASE 5 0.0011
490 MOUTH HAEMORRHAGE 8 0.0011
491 LUMBAR VERTEBRAL FRACTURE 5 0.0011
492 PNEUMONIA BACTERIAL 10 0.0011
493 ACUTE KIDNEY INJURY 165 0.0011
494 NECROSIS 6 0.0011
495 HYPERGLYCAEMIA 39 0.0011
496 PREMATURE DELIVERY 17 0.0011
497 CANDIDA INFECTION 18 0.0011
498 SKIN TIGHTNESS 5 0.0011
499 REBOUND EFFECT 12 0.0011
500 CYTOPENIA 13 0.0011
501 DIALYSIS 15 0.0011
502 ARTERIOSCLEROSIS CORONARY ARTERY 7 0.0011
503 TROPONIN INCREASED 8 0.0011
504 CHILLS 123 0.0010
505 HYPERTHERMIA 8 0.0010
506 ANAEMIA 198 0.0010
507 COLITIS ISCHAEMIC 7 0.0010
508 WRONG PRODUCT ADMINISTERED 7 0.0010
509 HYPERTRIGLYCERIDAEMIA 6 0.0010
510 EPIGASTRIC DISCOMFORT 4 0.0010
511 ECCHYMOSIS 7 0.0010
512 VENOUS THROMBOSIS 4 0.0010
513 BREATH SOUNDS ABNORMAL 5 0.0010
514 RIGHT VENTRICULAR FAILURE 7 0.0010
515 PYREXIA 344 0.0010
516 MYASTHENIA GRAVIS 8 0.0010
517 URINARY RETENTION 33 0.0010
518 ADRENAL INSUFFICIENCY 12 0.0010
519 HEPATOTOXICITY 22 0.0010
520 PULMONARY CONGESTION 13 0.0010
521 NEUTROPENIC SEPSIS 7 0.0010
522 DELIRIUM 34 0.0010
523 ENDOCARDITIS 5 0.0010
524 BRAIN DEATH 3 0.0010
525 EUGLYCAEMIC DIABETIC KETOACIDOSIS 4 0.0010
526 WHITE BLOOD CELL COUNT DECREASED 104 0.0010
527 PULSELESS ELECTRICAL ACTIVITY 4 0.0010
528 BILE DUCT STONE 3 0.0009
529 FEBRILE BONE MARROW APLASIA 4 0.0009
530 LEFT VENTRICULAR HYPERTROPHY 4 0.0009
531 ALTERED STATE OF CONSCIOUSNESS 20 0.0009
532 ANXIETY 262 0.0009
533 PERITONITIS 19 0.0009
534 SINUS TACHYCARDIA 13 0.0009
535 PULMONARY HYPERTENSION 19 0.0009
536 CARDIO-RESPIRATORY ARREST 38 0.0009
537 THYROID DISORDER 14 0.0009
538 ABDOMINAL ABSCESS 4 0.0009
539 GASTRIC ULCER HAEMORRHAGE 5 0.0009
540 LIVER DISORDER 40 0.0009
541 PNEUMOCYSTIS JIROVECII PNEUMONIA 9 0.0009
542 LEFT VENTRICULAR DYSFUNCTION 6 0.0009
543 GASTROINTESTINAL INFECTION 8 0.0009
544 NEOPLASM PROGRESSION 31 0.0009
545 TRICUSPID VALVE INCOMPETENCE 7 0.0009
546 THERAPY NON-RESPONDER 39 0.0009
547 HAEMOGLOBIN DECREASED 89 0.0009
548 LACTIC ACIDOSIS 28 0.0009
549 PRODUCT LABEL CONFUSION 5 0.0009
550 ERYTHEMA MULTIFORME 8 0.0009
551 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 47 0.0009
552 HICCUPS 7 0.0009
553 VENTRICULAR TACHYCARDIA 14 0.0008
554 PNEUMONIA 274 0.0008
555 PLEURISY 5 0.0008
556 CARDIAC TAMPONADE 4 0.0008
557 HYPERLIPIDAEMIA 10 0.0008
558 PREMATURE BABY 25 0.0008
559 FACE OEDEMA 14 0.0008
560 MENTAL STATUS CHANGES 23 0.0008
561 RASH VESICULAR 4 0.0008
562 ASPIRATION 9 0.0008
563 JOINT RANGE OF MOTION DECREASED 11 0.0008
564 CARDIOMEGALY 10 0.0008
565 DIABETIC NEUROPATHY 4 0.0008
566 PYELONEPHRITIS 7 0.0008
567 DRUG TOXICITY 11 0.0008
568 INTERNATIONAL NORMALISED RATIO INCREASED 23 0.0008
569 INTESTINAL PERFORATION 9 0.0008
570 PANCREATITIS ACUTE 18 0.0008
571 MITRAL VALVE INCOMPETENCE 9 0.0008
572 EMPHYSEMA 8 0.0008
573 BRADYCARDIA 42 0.0008
574 GASTROINTESTINAL HAEMORRHAGE 66 0.0008
575 PROTEINURIA 15 0.0008
576 BONE MARROW FAILURE 16 0.0008
577 BODY TEMPERATURE INCREASED 16 0.0008
578 DEPRESSED LEVEL OF CONSCIOUSNESS 31 0.0008
579 CHOLESTASIS 15 0.0008
580 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 4 0.0008
581 MYDRIASIS 10 0.0008
582 CEREBRAL INFARCTION 19 0.0008
583 PERIPHERAL VASCULAR DISORDER 4 0.0008
584 POST PROCEDURAL HAEMORRHAGE 9 0.0008
585 VASCULITIS 9 0.0008
586 MELAENA 17 0.0008
587 LUNG INFECTION 12 0.0008
588 ACUTE MYELOID LEUKAEMIA 12 0.0008
589 APLASTIC ANAEMIA 4 0.0008
590 RASH MACULO-PAPULAR 17 0.0008
591 BLOOD THYROID STIMULATING HORMONE INCREASED 7 0.0008
592 VIROLOGIC FAILURE 4 0.0007
593 GINGIVITIS 4 0.0007
594 ERYTHEMA OF EYELID 4 0.0007
595 PANCREATITIS 39 0.0007
596 SKIN ULCER 19 0.0007
597 POST PROCEDURAL COMPLICATION 14 0.0007
598 ANAPHYLACTOID REACTION 3 0.0007
599 MUCOSAL INFLAMMATION 19 0.0007
600 ENCEPHALITIS 5 0.0007
601 CHEST DISCOMFORT 74 0.0007
602 INFUSION RELATED REACTION 47 0.0007
603 CHROMATURIA 16 0.0007
604 AORTIC VALVE INCOMPETENCE 3 0.0007
605 GRANULOCYTOPENIA 4 0.0007
606 INTERSTITIAL LUNG DISEASE 34 0.0007
607 CHOLELITHIASIS 23 0.0007
608 DRUG-INDUCED LIVER INJURY 22 0.0007
609 HAEMATURIA 24 0.0007
610 DRUG RESISTANCE 18 0.0007
611 CARDIAC VALVE DISEASE 4 0.0007
612 RHABDOMYOLYSIS 29 0.0007
613 PSYCHOLOGICAL TRAUMA 6 0.0007
614 MYOPATHY 6 0.0007
615 DISEASE PROGRESSION 82 0.0007
616 METABOLIC DISORDER 4 0.0007
617 PETECHIAE 7 0.0007
618 HAEMOLYTIC ANAEMIA 6 0.0007
619 HYDRONEPHROSIS 5 0.0007
620 ATRIAL FIBRILLATION 65 0.0007
621 ELECTROCARDIOGRAM QT PROLONGED 24 0.0007
622 ANAL INCONTINENCE 6 0.0007
623 GENERAL PHYSICAL HEALTH DETERIORATION 77 0.0007
624 HEPATOCELLULAR CARCINOMA 5 0.0007
625 BUNDLE BRANCH BLOCK RIGHT 3 0.0007
626 RESPIRATORY DEPRESSION 8 0.0007
627 PROCEDURAL COMPLICATION 5 0.0007
628 MATERNAL EXPOSURE DURING PREGNANCY 58 0.0007
629 APNOEA 5 0.0006
630 DEFORMITY 6 0.0006
631 BLOOD TEST ABNORMAL 9 0.0006
632 COMA 30 0.0006
633 RENAL CYST 5 0.0006
634 ATRIAL FLUTTER 5 0.0006
635 ABDOMINAL DISTENSION 65 0.0006
636 BLOOD CALCIUM DECREASED 7 0.0006
637 HYPERTHYROIDISM 9 0.0006
638 HIATUS HERNIA 8 0.0006
639 HERPES SIMPLEX 4 0.0006
640 CEREBRAL HAEMORRHAGE 22 0.0006
641 REFUSAL OF TREATMENT BY PATIENT 4 0.0006
642 ESCHERICHIA INFECTION 5 0.0006
643 ORAL CANDIDIASIS 8 0.0006
644 DISABILITY 12 0.0006
645 ANEURYSM 3 0.0006
646 MENINGITIS 4 0.0006
647 NEUTROPENIA 81 0.0006
648 PERITONITIS BACTERIAL 6 0.0006
649 HAEMATEMESIS 15 0.0006
650 ARRHYTHMIA 28 0.0006
651 OEDEMA PERIPHERAL 72 0.0006
652 GENERAL PHYSICAL CONDITION ABNORMAL 4 0.0006
653 MOTOR DYSFUNCTION 6 0.0006
654 DEVICE RELATED INFECTION 9 0.0006
655 EJECTION FRACTION DECREASED 9 0.0006
656 HAEMATOMA 15 0.0006
657 VENTRICULAR EXTRASYSTOLES 6 0.0006
658 NERVOUS SYSTEM DISORDER 18 0.0006
659 NO THERAPEUTIC RESPONSE 7 0.0006
660 HAEMOPTYSIS 16 0.0006
661 TRANSFUSION 6 0.0006
662 DUODENAL ULCER 4 0.0006
663 RASH ERYTHEMATOUS 27 0.0006
664 DIVERTICULUM 4 0.0006
665 RED BLOOD CELL COUNT DECREASED 16 0.0006
666 CONVULSION 32 0.0006
667 SUBDURAL HAEMATOMA 8 0.0006
668 BLOOD POTASSIUM INCREASED 9 0.0006
669 LIVER FUNCTION TEST ABNORMAL 16 0.0005
670 WOUND INFECTION 6 0.0005
671 MALIGNANT NEOPLASM PROGRESSION 56 0.0005
672 GRAND MAL CONVULSION 5 0.0005
673 RESPIRATORY DISORDER 16 0.0005
674 TUBULOINTERSTITIAL NEPHRITIS 10 0.0005
675 BLOOD POTASSIUM DECREASED 16 0.0005
676 INFECTION 77 0.0005
677 DYSPNOEA 301 0.0005
678 STATUS EPILEPTICUS 6 0.0005
679 HAEMATOTOXICITY 5 0.0005
680 AORTIC ANEURYSM 4 0.0005
681 SCAR 9 0.0005
682 PAIN 322 0.0005
683 GASTRIC HAEMORRHAGE 6 0.0005
684 BLOOD URIC ACID INCREASED 3 0.0005
685 ATRIOVENTRICULAR BLOCK 4 0.0005
686 VITAMIN D DEFICIENCY 5 0.0005
687 PERIPHERAL COLDNESS 7 0.0005
688 BLOOD TRIGLYCERIDES INCREASED 9 0.0005
689 RESPIRATORY ARREST 14 0.0005
690 GALLBLADDER DISORDER 9 0.0005
691 POLYNEUROPATHY 6 0.0005
692 MIOSIS 4 0.0005
693 CARDIAC FAILURE CONGESTIVE 40 0.0005
694 PULMONARY EMBOLISM 47 0.0005
695 GASTRITIS 13 0.0005
696 HEPATOCELLULAR INJURY 7 0.0005
697 FOETAL EXPOSURE DURING PREGNANCY 40 0.0005
698 SUBARACHNOID HAEMORRHAGE 5 0.0005
699 SMALL INTESTINAL OBSTRUCTION 6 0.0005
700 SPINAL COMPRESSION FRACTURE 4 0.0005
701 HEMIPLEGIA 4 0.0005
702 EOSINOPHIL COUNT INCREASED 4 0.0005
703 HAEMORRHAGE 50 0.0005
704 PALLOR 13 0.0005
705 UPPER GASTROINTESTINAL HAEMORRHAGE 8 0.0005
706 ACUTE MYOCARDIAL INFARCTION 14 0.0005
707 MOUTH ULCERATION 10 0.0005
708 CARDIOVASCULAR DISORDER 12 0.0005
709 LUNG DISORDER 23 0.0005
710 MENTAL DISORDER 20 0.0005
711 EPILEPSY 14 0.0005
712 HYPERTENSION 97 0.0005
713 EOSINOPHILIA 8 0.0005
714 HEART RATE INCREASED 45 0.0005
715 ADVERSE REACTION 6 0.0005
716 BLOOD CREATINE PHOSPHOKINASE INCREASED 13 0.0005
717 URINARY TRACT INFECTION 77 0.0005
718 DEEP VEIN THROMBOSIS 29 0.0004
719 URTICARIA 74 0.0004
720 DEPRESSION 100 0.0004
721 URINARY INCONTINENCE 13 0.0004
722 MYOCARDITIS 5 0.0004
723 OFF LABEL USE 378 0.0004
724 CONFUSIONAL STATE 69 0.0004
725 FLANK PAIN 4 0.0004
726 ARTERIOSCLEROSIS 4 0.0004
727 RETCHING 9 0.0004
728 GASTRIC ULCER 8 0.0004
729 RECTAL HAEMORRHAGE 18 0.0004
730 EXPOSURE DURING PREGNANCY 26 0.0004
731 MUSCLE RIGIDITY 5 0.0004
732 DRUG INTERACTION 66 0.0004
733 HYPERSENSITIVITY 77 0.0004
734 HYPERCHOLESTEROLAEMIA 4 0.0004
735 PULMONARY ARTERIAL HYPERTENSION 6 0.0004
736 HAEMORRHOIDS 8 0.0004
737 BLINDNESS TRANSIENT 3 0.0004
738 BLOOD PRESSURE DIASTOLIC DECREASED 3 0.0004
739 CONTUSION 39 0.0004
740 TREATMENT NONCOMPLIANCE 22 0.0004
741 BRAIN INJURY 4 0.0004
742 INTESTINAL OBSTRUCTION 15 0.0004
743 TOXIC SKIN ERUPTION 4 0.0004
744 COLITIS 15 0.0004
745 LYMPHADENOPATHY 14 0.0004
746 ABDOMINAL PAIN LOWER 10 0.0004
747 ANOREXIA 5 0.0004
748 DIABETES MELLITUS 29 0.0004
749 CEREBROVASCULAR ACCIDENT 64 0.0004
750 CONJUNCTIVITIS 7 0.0004
751 CELLULITIS 19 0.0004
752 AGRANULOCYTOSIS 7 0.0004
753 HYPOTHYROIDISM 12 0.0004
754 DEHYDRATION 50 0.0004
755 PHOTOPHOBIA 7 0.0004
756 POOR QUALITY SLEEP 8 0.0004
757 WHEEZING 22 0.0004
758 BLOOD URINE PRESENT 7 0.0004
759 GASTROINTESTINAL PAIN 4 0.0004
760 TREATMENT FAILURE 30 0.0004
761 ABDOMINAL PAIN 84 0.0004
762 TRANSAMINASES INCREASED 8 0.0004
763 PRODUCTIVE COUGH 17 0.0004
764 RESTLESSNESS 13 0.0004
765 ERYTHEMA 73 0.0004
766 PRODUCT USE IN UNAPPROVED INDICATION 88 0.0004
767 SKIN REACTION 5 0.0004
768 HYPOGLYCAEMIA 17 0.0004
769 HALLUCINATION 26 0.0003
770 EYELID OEDEMA 4 0.0003
771 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 8 0.0003
772 HEART RATE DECREASED 12 0.0003
773 BLISTER 19 0.0003
774 CHOLECYSTITIS 4 0.0003
775 CONDITION AGGRAVATED 101 0.0003
776 OSTEOMYELITIS 6 0.0003
777 FUNGAL INFECTION 11 0.0003
778 ECONOMIC PROBLEM 5 0.0003
779 STOMATITIS 20 0.0003
780 OSTEOPENIA 5 0.0003
781 LIVER INJURY 8 0.0003
782 RASH 142 0.0003
783 GLOMERULAR FILTRATION RATE DECREASED 4 0.0003
784 LYMPHOMA 5 0.0003
785 BLOOD SODIUM DECREASED 6 0.0003
786 DIARRHOEA 202 0.0003
787 HEPATITIS 8 0.0003
788 LOSS OF CONSCIOUSNESS 40 0.0003
789 COUGH 87 0.0003
790 METASTASES TO CENTRAL NERVOUS SYSTEM 4 0.0003
791 PRURITUS 119 0.0003
792 HAEMATOCHEZIA 17 0.0003
793 BLOOD PRESSURE INCREASED 47 0.0003
794 NERVOUSNESS 16 0.0003
795 LABORATORY TEST ABNORMAL 9 0.0003
796 UPPER RESPIRATORY TRACT INFECTION 14 0.0003
797 SKIN DISORDER 10 0.0003
798 DYSURIA 11 0.0003
799 FLUSHING 30 0.0003
800 CENTRAL NERVOUS SYSTEM LESION 4 0.0003
801 CHEST PAIN 53 0.0003
802 RASH MACULAR 10 0.0003
803 SEIZURE 33 0.0003
804 INTENTIONAL PRODUCT USE ISSUE 25 0.0003
805 DYSPHAGIA 27 0.0003
806 PALPITATIONS 33 0.0003
807 EPISTAXIS 21 0.0003
808 PARALYSIS 4 0.0003
809 RENAL DISORDER 13 0.0003
810 HEPATIC ENZYME INCREASED 19 0.0003
811 DISCOMFORT 17 0.0003
812 DISORIENTATION 11 0.0003
813 COMPLICATION ASSOCIATED WITH DEVICE 4 0.0003
814 END STAGE RENAL DISEASE 5 0.0003
815 HYPOPHAGIA 7 0.0003
816 EYE DISORDER 9 0.0003
817 COVID-19 48 0.0003
818 DEATH 233 0.0003
819 MEDICATION ERROR 15 0.0003
820 RESPIRATORY TRACT INFECTION 7 0.0003
821 HEPATIC STEATOSIS 5 0.0003
822 LUNG NEOPLASM MALIGNANT 11 0.0003
823 TREMOR 44 0.0003
824 FLATULENCE 15 0.0003
825 CORONARY ARTERY DISEASE 8 0.0003
826 PRODUCT AVAILABILITY ISSUE 6 0.0003
827 INSURANCE ISSUE 4 0.0003
828 MUSCLE TWITCHING 6 0.0003
829 THERAPY PARTIAL RESPONDER 4 0.0003
830 FLUID RETENTION 13 0.0003
831 KIDNEY INFECTION 5 0.0003
832 DISEASE RECURRENCE 12 0.0003
833 DIABETIC KETOACIDOSIS 6 0.0002
834 HYPERHIDROSIS 32 0.0002
835 MUSCLE TIGHTNESS 4 0.0002
836 DECREASED APPETITE 57 0.0002
837 AGITATION 18 0.0002
838 ANGINA PECTORIS 7 0.0002
839 DRUG LEVEL INCREASED 4 0.0002
840 DRUG INEFFECTIVE 318 0.0002
841 NEPHROLITHIASIS 11 0.0002
842 MUSCULAR WEAKNESS 27 0.0002
843 HEMIPARESIS 4 0.0002
844 VOMITING 108 0.0002
845 SPEECH DISORDER 12 0.0002
846 METASTASES TO LIVER 4 0.0002
847 HERPES ZOSTER 13 0.0002
848 RASH PAPULAR 5 0.0002
849 ADVERSE EVENT 20 0.0002
850 FEELING COLD 6 0.0002
851 TOXICITY TO VARIOUS AGENTS 36 0.0002
852 SLEEP APNOEA SYNDROME 4 0.0002
853 ASTHENIA 78 0.0002
854 BONE PAIN 12 0.0002
855 NAUSEA 161 0.0002
856 RASH PRURITIC 11 0.0002
857 BRONCHITIS 15 0.0002
858 ACTIVITIES OF DAILY LIVING IMPAIRED 4 0.0002
859 MYOCARDIAL INFARCTION 35 0.0002
860 THROAT IRRITATION 9 0.0002
861 GLYCOSYLATED HAEMOGLOBIN INCREASED 5 0.0002
862 CONSTIPATION 43 0.0002
863 MOBILITY DECREASED 14 0.0002
864 EMOTIONAL DISORDER 6 0.0002
865 CARDIAC DISORDER 18 0.0002
866 POLLAKIURIA 8 0.0002
867 ACCIDENTAL OVERDOSE 7 0.0002
868 DERMATITIS 4 0.0002
869 JOINT STIFFNESS 5 0.0002
870 OVERDOSE 41 0.0002
871 DRUG INTOLERANCE 18 0.0002
872 DYSPNOEA EXERTIONAL 7 0.0002
873 PAIN OF SKIN 5 0.0002
874 PRURITUS GENERALISED 4 0.0002
875 DRY MOUTH 15 0.0002
876 FAECES DISCOLOURED 4 0.0002
877 SWELLING FACE 12 0.0002
878 PRODUCT DISPENSING ERROR 4 0.0002
879 PRODUCT PRESCRIBING ISSUE 4 0.0002
880 THERAPEUTIC RESPONSE DECREASED 11 0.0002
881 VIRAL INFECTION 6 0.0002
882 COLITIS ULCERATIVE 8 0.0002
883 WEIGHT INCREASED 39 0.0002
884 BLINDNESS 7 0.0002
885 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 5 0.0002
886 SYNCOPE 17 0.0002
887 BLOOD GLUCOSE INCREASED 32 0.0002
888 BLOOD PRESSURE FLUCTUATION 4 0.0002
889 PRESYNCOPE 4 0.0002
890 FALL 54 0.0002
891 BALANCE DISORDER 14 0.0002
892 LIMB DISCOMFORT 5 0.0002
893 SWOLLEN TONGUE 5 0.0002
894 DYSARTHRIA 6 0.0002
895 CHRONIC KIDNEY DISEASE 12 0.0002
896 MOVEMENT DISORDER 5 0.0002
897 PHARMACEUTICAL PRODUCT COMPLAINT 4 0.0002
898 BLOOD PRESSURE SYSTOLIC INCREASED 3 0.0002
899 SKIN DISCOLOURATION 7 0.0002
900 ABNORMAL BEHAVIOUR 6 0.0002
901 NEOPLASM MALIGNANT 10 0.0001
902 OCULAR HYPERAEMIA 7 0.0001
903 SKIN LESION 4 0.0001
904 BACK PAIN 33 0.0001
905 LETHARGY 8 0.0001
906 SWELLING 13 0.0001
907 PANCREATIC CARCINOMA 4 0.0001
908 NO ADVERSE EVENT 25 0.0001
909 DYSPHONIA 8 0.0001
910 APPLICATION SITE PAIN 3 0.0001
911 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 7 0.0001
912 ECZEMA 7 0.0001
913 APHASIA 4 0.0001
914 SKIN EXFOLIATION 11 0.0001
915 MYALGIA 22 0.0001
916 WEIGHT DECREASED 36 0.0001
917 FATIGUE 99 0.0001
918 CYSTITIS 4 0.0001
919 EYE PAIN 7 0.0001
920 GASTROINTESTINAL DISORDER 11 0.0001
921 IMPAIRED HEALING 4 0.0001
922 LIP SWELLING 4 0.0001
923 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 4 0.0001
924 THERAPY CESSATION 6 0.0001
925 NEUROPATHY PERIPHERAL 11 0.0001
926 VAGINAL HAEMORRHAGE 5 0.0001
927 BURNING SENSATION 8 0.0001
928 HYPOAESTHESIA 17 0.0001
929 THERAPEUTIC RESPONSE UNEXPECTED 5 0.0001
930 GAIT DISTURBANCE 21 0.0001
931 SOMNOLENCE 22 0.0001
932 AMNESIA 7 0.0001
933 EYE SWELLING 4 0.0001
934 NECK PAIN 6 0.0001
935 ASTHMA 12 0.0001
936 EYE IRRITATION 6 0.0001
937 PLASMA CELL MYELOMA 4 0.0001
938 DYSPEPSIA 10 0.0001
939 PRODUCT USE ISSUE 19 0.0001
940 MALAISE 44 0.0001
941 AGGRESSION 5 0.0001
942 THROMBOSIS 8 0.0001
943 DYSKINESIA 4 0.0001
944 THERAPY INTERRUPTED 7 0.0001
945 OSTEOPOROSIS 4 0.0001
946 INFLAMMATION 5 0.0001
947 PAIN IN EXTREMITY 28 0.0001
948 INTENTIONAL OVERDOSE 6 0.0001
949 DIZZINESS 46 0.0001
950 INFLUENZA 10 0.0001
951 THERAPEUTIC PRODUCT EFFECT DECREASED 4 0.0001
952 INSOMNIA 23 0.0001
953 COGNITIVE DISORDER 4 0.0001
954 INFLUENZA LIKE ILLNESS 7 0.0001
955 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 6 0.0001
956 PARAESTHESIA 13 0.0001
957 FEELING HOT 5 0.0001
958 MEMORY IMPAIRMENT 11 0.0001
959 RHEUMATOID ARTHRITIS 9 0.0001
960 PERIPHERAL SWELLING 12 0.0001
961 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 14 0.0001
962 GASTROOESOPHAGEAL REFLUX DISEASE 6 0.0001
963 VISION BLURRED 10 0.0001
964 ABDOMINAL DISCOMFORT 12 0.0001
965 MUSCULOSKELETAL STIFFNESS 6 0.0001
966 SURGERY 4 0.0001
967 NASAL CONGESTION 4 0.0001
968 ABDOMINAL PAIN UPPER 14 0.0001
969 ANGIOEDEMA 3 0.0001
970 DRY SKIN 9 0.0001
971 ILL-DEFINED DISORDER 4 0.0001
972 BLOOD CHOLESTEROL INCREASED 3 0.0001
973 BLOOD GLUCOSE DECREASED 3 0.0001
974 RHINORRHOEA 4 0.0001
975 HEADACHE 37 0.0001
976 SLEEP DISORDER 4 0.0001
977 ADVERSE DRUG REACTION 5 0.0001
978 FEELING ABNORMAL 13 0.0001
979 ACNE 4 0.0001
980 PRODUCT QUALITY ISSUE 7 0.0001
981 ARTHRITIS 4 0.0001
982 ILLNESS 5 0.0000
983 MUSCLE SPASMS 8 0.0000
984 OROPHARYNGEAL PAIN 4 0.0000
985 PRODUCT DOSE OMISSION ISSUE 12 0.0000
986 ALOPECIA 8 0.0000
987 VISUAL IMPAIRMENT 5 0.0000
988 INCORRECT DOSE ADMINISTERED 9 0.0000
989 HOSPITALISATION 6 0.0000
990 SINUSITIS 4 0.0000
991 NASOPHARYNGITIS 7 0.0000
992 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 5 0.0000
993 ARTHRALGIA 10 0.0000
994 INJECTION SITE PAIN 4 0.0000